Vendor Audit, Qualification, and Selection Management


CLIENT OVERVIEW 

A cell and gene therapy company scaling development programs and preparing to onboard new vendors for plasmids, viral vectors, raw materials, and steriles.


CLIENT CHALLENGE 

Internal staff lacked bandwidth to conduct structured vendor qualification and audits. Supplier compliance maturity varied significantly and required assessment.


PIONEER ENGAGEMENT 

  • Designed risk-based vendor management program 

  • Conducted remote and on-site audits for plasmid, vector, raw material, and sterile manufacturers 

  • Delivered audit reports, corrective actions, and follow-up tracking 

  • Completed vendor capability assessments and benchmarking 

  • Built vendor selection scoring model 

  • Supported contract and quality agreement negotiations


KEY DELIVERABLES 

  •  Vendor management program 

  • Audit reports and CAPA plans 

  • Vendor capability assessments 

  • Vendor scoring matrix 

  • Quality agreement templates


OUTCOME 

The company established a reliable, fully qualified vendor network, improved supply chain performance, and reduced compliance risk.


Ready to get Started with Pioneer GMP Consulting?

Previous
Previous

CSA vs. CSV: Understanding FDA's Computer Software Assurance Approach and What It Means for Your Validation Program

Next
Next

CMC Acceleration for an ATMP Development Portfolio